Domov › Glioblastóm › Pennsylvania
Klinické štúdie Glioblastóm v štáte Pennsylvania
21 štúdií pre Glioblastóm hľadá účastníkov v zariadeniach v štáte Pennsylvania.
Mestá v štáte Pennsylvania
Oficiálny text štúdie (anglicky)
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
- Penn State Health Milton S. Hershey Medical Center, Hershey
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT05902169Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Allegheny Health Network, Pittsburgh
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT07195591Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
- UPMC Hillman Cancer Center, Pittsburgh
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT05432804A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
Prebieha náborFáza 2/3
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT03970447Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07326566A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia
Prebieha náborFáza 1/2
Do veku 25 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT04094610Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma
- Hospital of the University of Pennsylvania, Philadelphia
- University of Pennsylvania, Philadelphia
Prebieha náborSkorá fáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT06613841Targeted Pediatric High-Grade Glioma Therapy
- Children's Hospital of Philadelphia, Philadelphia
Prebieha náborObservačná štúdia
12 Months – 39 Years · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT05839379Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- UPMC Hillman Cancer Center, Pittsburgh
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT06860594Study of Olutasidenib and Temozolomide in HGG
- Children's Hospital of Philadelphia, Philadelphia
Prebieha náborFáza 2
Vek 12 až 39 · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Thomas Jefferson University Hospital, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 8. 2026 · NCT05303519INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- University of Pittsburgh Medical Center, Pittsburgh
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 19. 8. 2026 · NCT02977780WBSI Guided Personalized Delivery of TTFields
- Abramson Cancer Center, Philadelphia
- Penn Medicine, University of Pennsylvania, Philadelphia
Prebieha nábor
Vek 22 a viac · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT05086497Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
- Penn State Milton S. Hershey Medical Center, Hershey
Prebieha náborFáza 2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 17. 7. 2026 · NCT07225621DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
- UPMC Presbyterian Hospital, Pittsburgh
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 7. 2026 · NCT06805305Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Children's Hospital of Philadelphia, Philadelphia
Prebieha náborSkorá fáza 1Vítaní zdravých dobrovoľníkov
Vek 1 až 21 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT06333899Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- University of Pittsburg Medical Center (UPCM), Pittsburgh
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 6. 2026 · NCT05283330ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- Children's Hospital of Philadelphia, Philadelphia
Prebieha náborFáza 1
Vek 2 až 21 · Všetky pohlavia · Aktualizované 11. 6. 2026 · NCT04732065Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Children's Hospital of Philadelphia, Philadelphia
Prebieha náborFáza 2
12 Months – 39 Years · Všetky pohlavia · Aktualizované 29. 5. 2026 · NCT05843253SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Philadelphia
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Penn State Milton S. Hershey Medical Center, Hershey
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 6. 2025 · NCT03175224Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.